Head and Neck Cancers Coverage from Every Angle

Recent News

NCI-MATCH Trial Subprotocol: T-DM1 in HER2-Positive Salivary Gland Tumors
HPV Status May Influence Mortality Rates in Patients With Oropharyngeal Cancer
KEYNOTE-048 Opens Door Farther for Pembrolizumab in Head/Neck Cancer
PDK1 Inhibition and Resistance to Cetuximab in Head/Neck Squamous Cell Carcinoma
RSNA 2019: Brachytherapy for Elderly Patients With Skin Cancer of the Head/Neck
Late Cranial Neuropathy in Survivors of Head and Neck Cancer
Patients With Head/Neck Cancer Prefer Dietary Counseling Before Treatment, Study Finds
Triple Metronomic Chemotherapy for Platinum-Refractory Oral Cancer
Connecting LncRNA Molecule to Development of Head/Neck Squamous Cell Carcinoma
Tipifarnib in HRAS-Mutant Head/Neck Squamous Cell Carcinomas
Personalization of Treatment Based on Fitness in Elderly Patients With Head/Neck Cancer
Study Identifies Risk Factors for Head/Neck Cancer in World Trade Center Responders
ESMO 2019: Monalizumab Monotherapy for Resistant Head/Neck Cancer
ESMO 2019: Locoregional Radiotherapy Plus Chemotherapy for Nasopharyngeal Carcinoma
ASTRO 2019: Adding Cisplatin to Radiation Therapy in Advanced Oropharyngeal Cancer
ASTRO 2019: Can Taking Aspiring During Chemoradiotherapy Improve Outcomes in Head/Neck Cancer?
ASTRO 2019: Circulating Tumor DNA and Survival in HPV-Positive Oropharyngeal Cancer
ASTRO 2019: Predicting Radiation Toxicity in Head/Neck Cancer With Machine-Learning Model
Does Cigarette Smoke Prompt Head and Neck Cancer Aggressiveness?
Quality Care 2019: Hearing Screening After Treatment for Head and Neck Cancers
Radiotherapy Versus Surgery in Oropharyngeal Cancer: Quality of Life From ORATOR Trial
Adding Nimotuzumab to Chemoradiotherapy in Locally Advanced Head and Neck Cancer
Adding Palbociclib to Cetuximab in Platinum-Resistant Head and Neck Cancer
Novel Monoclonal Antibody Plus Cetuximab Under Study in Head/Neck Cancer
Statin Use After Radiotherapy for Head and Neck Cancer Survivors
FDA Approves Pembrolizumab in PD-L1–Expressing Squamous Cell Carcinoma of the Esophagus
Differentiating Treatment Levels for HPV-Linked Oropharyngeal Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.